Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

July 28, 2015 6:53 PM ET

Healthcare Providers and Services

Company Overview of Atherotech, Inc.

Company Overview

Atherotech, Inc. operates a diagnostic testing and disease management company. The company offers vertical auto profile test that measures the cholesterol content of all lipids, components, and subclasses. It provides testing services to physicians, hospitals, clinics, and other laboratories in the United States. The company was founded in 1996 and is headquartered in Birmingham, Alabama.

201 London Parkway

Birmingham, AL 35211

United States

Founded in 1996





Key Executives for Atherotech, Inc.

Chief Executive Officer, President and Director
Chief Operations Officer
Chief Medical Officer and Member of Medical Advisory Board
Vice President of Human Resources
Compensation as of Fiscal Year 2015.

Atherotech, Inc. Key Developments

Atherotech Diagnostics Lab Appoints Gerard Abate as Chief Clinical Officer

Atherotech Diagnostics Lab announced the addition of Gerard Abate, M.D., as the company's Chief Clinical Officer. Abate spent 14 years as a non-invasive clinical cardiologist and owner of Williamsburg Cardiology in Williamsburg, Va. He most recently served as Senior Medical Director for Thrombosis in Medical Affairs at Daiichi Sankyo.

Johns Hopkins, Atherotech Announce Strategic Research Collaboration to Fight Heart Disease

Atherotech Diagnostics Lab announced a strategic research collaboration with the Johns Hopkins Ciccarone Center for the Prevention of Heart Disease. The partnership pairs Atherotech's Very Large Database of Lipids (VLDL) with Johns Hopkins' world-class cardiac research capabilities. The project's goal is to generate new knowledge through research, and translate that knowledge into clinical practice in the fight against cardiovascular disease. Using its proprietary VAP(R) Lipid Panel, Atherotech is the only company to consistently assess cholesterol-rich risk with directly measured LDL, HDL and subclasses; triglyceride-rich risk in remnant lipoproteins; and hereditary risk with Lp(a) -- all of which are represented in the total VLDL database of 8 million samples. The current research VLDL dataset has 1.4 million data points representing unique individuals, with more than 3 million data points anticipated for the next data harvest.

Similar Private Companies By Industry

Company Name Region
Avant Care Home Health Care, Inc. United States
Visiting Nurse Association of Cape Cod Inc. United States
Cardinal Health 412, Inc. United States
Financial Health Services, LLC United States
Tuscaloosa Surgical Center United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Atherotech, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at